Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000146103 | SCV000193320 | uncertain significance | Hyperinsulinemic hypoglycemia, familial, 2 | 2014-02-24 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002227072 | SCV002505933 | benign | Hyperinsulinemic hypoglycemia | criteria provided, single submitter | research | Mutations in KCNJ11 gene can cause decreased production and secretion of insulin. This can lead to MODY which is responsive to oral sulfonylureas. This particular variant rs587783666 is associated with persistent hyperinsulinemic hypoglycemia of infancy. | |
Labcorp Genetics |
RCV005089683 | SCV005835828 | uncertain significance | not provided | 2024-11-15 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 54 of the KCNJ11 protein (p.Arg54His). This variant is present in population databases (rs587783666, gnomAD 0.0009%). This missense change has been observed in individual(s) with congenital hyperinsulinism (PMID: 23345197). ClinVar contains an entry for this variant (Variation ID: 158673). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt KCNJ11 protein function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Seattle Children's Hospital Molecular Genetics Laboratory, |
RCV003445560 | SCV004174091 | likely pathogenic | Maturity-onset diabetes of the young type 13 | no assertion criteria provided | clinical testing |